@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_head { this: np:hasAssertion dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_assertion; np:hasProvenance dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_provenance; np:hasPublicationInfo dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_publicationInfo; a np:Nanopublication . dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_assertion a np:Assertion . dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_provenance a np:Provenance . dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_publicationInfo a np:PublicationInfo . } dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_assertion { miriam-gene:1917 a ncit:C16612 . lld:C0019196 a ncit:C7057 . dgn-gda:DGNdfbebc6ff760c9efacb7ff6977b8f3cb sio:SIO_000628 miriam-gene:1917, lld:C0019196; a sio:SIO_001121 . } dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_provenance { dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_assertion dcterms:description "[To determine whether baseline LDL or HDL levels and statin use affect SVR rates, we retrospectively evaluated the IDEAL (Individualized Dosing Efficacy Versus Flat Dosing to Assess Optimal Pegylated Interferon Therapy) trial, in which 3070 treatment-naive, hepatitis C virus (HCV) genotype 1-infected patients were treated for up to 48 weeks in one of the following arms: (1) peginterferon (PEG-IFN) alfa-2b at 1.5 microg/kg/week with ribavirin (RBV) at 800 to 1400 mg/day, (2) PEG-IFN alfa-2b at 1.0 microg/kg/week with RBV at 800 to 1400 mg/day, or (3) PEG-IFN alfa-2a at 180 microg/week with RBV at 1000 to 1200 mg/day.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:20568303; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP478963.RActqmfz7f4lfcs3dZH5Qgjufkrdw0mBFnWH92wmkni-I130_publicationInfo { this: dcterms:created "2014-10-02T12:36:47+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }